Latest Europe News

Page 17 of 133
Paradigm Biopharmaceuticals has achieved 50% patient enrolment in its pivotal Phase 3 trial for injectable pentosan polysulfate sodium, advancing steadily towards an interim analysis expected in August 2026.
Ada Torres
Ada Torres
31 Mar 2026
RocketBoots has secured a significant A$3.3 million activation contract with a leading multinational retailer, marking the start of a global deployment phase that complements its existing SaaS agreement and promises near-term revenue growth.
Sophie Babbage
Sophie Babbage
30 Mar 2026
Genetic Signatures is undertaking a major organisational restructure to cut costs by $5 million and sharpen its commercial focus, aiming to accelerate growth in its diagnostic product offerings.
Ada Torres
Ada Torres
30 Mar 2026
Cynata Therapeutics has completed the 100-day primary evaluation period for its Phase 2 trial of CYP-001 in acute graft versus host disease, with results expected in June 2026. This milestone marks a critical step for the biotech’s lead cell therapy candidate in a condition with few effective treatments.
Ada Torres
Ada Torres
30 Mar 2026
EML Payments has appointed Adam Olding as its Global CEO, marking a pivotal step in its EML 2.0 transformation and signalling strengthened leadership to drive growth. Concurrently, regulatory developments around its Australian banking licence application introduce new compliance dynamics.
Claire Turing
Claire Turing
30 Mar 2026
Ava Risk Group has announced a $7 million strategic investment from US-based Hale Capital to fuel its expansion into the US federal security market and accelerate product development. This partnership aims to position Ava as a global leader in critical infrastructure protection with a strong US presence.
Sophie Babbage
Sophie Babbage
30 Mar 2026
Fortuna Metals Limited (ASX:FUN) reports a major high-grade rutile discovery at its Mkanda project in Malawi, positioning itself to meet rising demand from aerospace and emerging robotics sectors amid a tightening global titanium market.
Maxwell Dee
Maxwell Dee
30 Mar 2026
4DMedical has achieved CE Mark certification for its groundbreaking CT:VQ™ ventilation-perfusion imaging technology, unlocking the vast European market. The company also raised $83 million to fund rapid expansion across the EU.
Ada Torres
Ada Torres
27 Mar 2026
Titomic Limited has secured a significant $1.7 million purchase order from the Netherlands’ Royal NLR, reinforcing its foothold in European aerospace and defense additive manufacturing.
Victor Sage
Victor Sage
27 Mar 2026
International Graphite Limited (IG6) has partnered with Italian chemical giant ALKEEMIA to establish a cutting-edge graphite processing facility in Italy, targeting production by late 2027. This joint venture aims to secure Europe's graphite supply chain amid rising demand and regulatory pressures.
Maxwell Dee
Maxwell Dee
26 Mar 2026
Ava Risk Group secures key government contracts and expands its technology trials in Australia, the US, and the Middle East during Q3 FY2026, reinforcing its position in critical infrastructure security.
Sophie Babbage
Sophie Babbage
26 Mar 2026
Eden Innovations reports robust expansion of its EdenCrete® concrete additives in North and South America, driven by new contracts with major ready-mix concrete producers. The company’s low-carbon products are gaining traction amid growing sustainability demands.
Maxwell Dee
Maxwell Dee
26 Mar 2026